difficile(C. diff) infection (CDI)in adults following antibacterial treatment for recurrent CDI.
Todays approval provides patients and healthcare providers a new way to help prevent recurrentC.
C. Diff Infection Causes 15,000 to 30,000 Deaths per Year
CDI, triggered by the bacteriumC.
Approximately 15,000 to 30,000 people die from the infection each year.
Is Vowst Safe?
Vowst may carry a risk of transmitting infectious agents, according to theFDA statement.
It is also possible for Vowst to contain food allergens, the agency noted.
The therapy is expected to be available beginning June 2023, according to theproduct website.
Thelist price for Vowst is $17,500, according to a company presentation.
The actual cost to consumers will depend on insurance coverage.
diffdiarrhea also benefit from Vowst, says Banaei.
Becky Upham has been professionally involved in health and wellness for almost 20 years.
Upham enjoys teaching cycling classes, running, reading fiction, and making playlists.
Think Again
Fecal Transplant for Ulcerative Colitis: Does It Work?
